Daniel L. Abravanel
0000-0002-0129-1618
Publication & Citation Trends
Publications
0 total
Abstract PS2-07-16: Clinicogenomic characterization and ctDNA detection of ESR1 fusion positive metastatic breast cancer
Cited by 0
Semantic Scholar
Abstract PS3-12-15: Mapping the imprint of taxane chemotherapy on the metastatic microenvironment in HR+ breast cancer with single cell and spatial profiling
Cited by 0
Semantic Scholar
Abstract PD2-09: Convergent genomic evolution from early to lethal HR+/HER2- metastatic breast cancer
Cited by 0
Semantic Scholar
Abstract PS4-04-19: A nucleic acid sensing system for selective therapeutic protein expression in breast cancer
Cited by 0
Semantic Scholar
Genomic landscape, immune microenvironment and survival in male versus female breast cancer
Cited by 0
Semantic Scholar
Abstract PS2-13-13: Mortality in HER2-positive male breast cancer between 2010 and 2022: A population-based study
Cited by 0
Semantic Scholar
Abstract PS2-02-07: Impact of BRCA homozygous copy loss on clinical outcomes of patients (pts) with metastatic breast cancer (MBC) treated with PARP inhibitors (PARPi)
Cited by 0
Semantic Scholar
Abstract 7265: MBCproject: multi-omic profiling of metastatic breast cancer evolution through patient-partnered research
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(18)
Single-cell and spatial transcriptomics
(11)
Advanced Breast Cancer Therapies
(11)
Cancer Cells and Metastasis
(8)
Breast Cancer Treatment Studies
(6)
Affiliations
Broad Institute
Brigham and Women's Hospital
Harvard University
Cancer Research Institute
Duke University